| A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3) (NCT05013229) | Novo Nordisk A/S | 2021-11-30 |
| A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes (NCT05144984) | Novo Nordisk A/S | 2021-11-29 |
| Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity (NCT05132088) | Novo Nordisk A/S | 2021-11-16 |
| A Research Study Looking Into Levels of the Medicine NNC0385-0434 in the Body and How Well it is Tolerated in Participants With Impaired Kidney Function Compared to Participants With Normal Kidney Function (NCT05094934) | Novo Nordisk A/S | 2021-11-09 |
| A Research Study Looking at New Protein-based Tablets in Healthy Male Participants (NCT05129891) | Novo Nordisk A/S | 2021-11-03 |
| A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice (NCT05069545) | Novo Nordisk A/S | 2021-10-11 |
| Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis (NCT05064735) | Novo Nordisk A/S | 2021-10-01 |
| Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10) (NCT05082116) | Novo Nordisk A/S | 2021-09-27 |
| Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1) (NCT05035095) | Novo Nordisk A/S | 2021-09-13 |
| A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets (NCT04817644) | Novo Nordisk A/S | 2021-09-10 |
| Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes (NCT05040971) | Novo Nordisk A/S | 2021-09-06 |
| A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People (NCT05046873) | Novo Nordisk A/S | 2021-09-06 |
| A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE) (NCT05035082) | Novo Nordisk A/S | 2021-09-01 |
| Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH) (NCT05016882) | Novo Nordisk A/S | 2021-08-31 |
| A Research Study Looking Into Blood Levels of the Medicine NNC0480-0389 in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function (NCT05015894) | Novo Nordisk A/S | 2021-08-30 |
| ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation (NCT05021835) | Novo Nordisk A/S | 2021-08-30 |
| Awareness, Care & Treatment In Obesity Management - An International Observation Among Teens (ACTION Teens) (NCT05013359) | Novo Nordisk A/S | 2021-08-23 |
| A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men (NCT05003440) | Novo Nordisk A/S | 2021-08-19 |
| A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease (NCT04992065) | Novo Nordisk A/S | 2021-08-03 |
| Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes (NCT04982575) | Novo Nordisk A/S | 2021-08-02 |
| A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day. (NCT04970654) | Novo Nordisk A/S | 2021-07-22 |
| A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity (NCT04969939) | Novo Nordisk A/S | 2021-07-15 |
| A Research Study of How a New Medicine NNC0365-3769 (Mim8) Works in the Body of Healthy People (NCT05127473) | Novo Nordisk A/S | 2021-07-14 |
| A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or Obesity (NCT04940078) | Novo Nordisk A/S | 2021-07-07 |
| Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes (NCT04916470) | Novo Nordisk A/S | 2021-06-15 |
| Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea (NCT04952779) | Novo Nordisk A/S | 2021-06-02 |
| Investigating the Effect of Ryzodeg® in Adult Patients With Type 2 Diabetes in Lebanon (NCT04892069) | Novo Nordisk A/S | 2021-05-27 |
| A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese Men (NCT04878406) | Novo Nordisk A/S | 2021-05-18 |
| A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) (NCT04777396) | Novo Nordisk A/S | 2021-05-18 |
| A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) (NCT04777409) | Novo Nordisk A/S | 2021-05-18 |
| A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4) (NCT04880850) | Novo Nordisk A/S | 2021-05-14 |
| A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical Practice (NCT04862923) | Novo Nordisk A/S | 2021-05-12 |
| A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6) (NCT04848480) | Novo Nordisk A/S | 2021-04-30 |
| A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical Practice (NCT04878393) | Novo Nordisk A/S | 2021-04-30 |
| A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial) (NCT04865770) | Novo Nordisk A/S | 2021-04-28 |
| A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People From China With Type 2 Diabetes (NCT04857398) | Novo Nordisk A/S | 2021-04-28 |
| A Study Investigating the Clinical Parameters Associated With the Use of Ryzodeg® (Insulin Degludec/Insulin Aspart) in a Real-world Adult Population With Type 2 Diabetes in South Korea (NCT04656106) | Novo Nordisk A/S | 2021-04-27 |
| GOAL: A Research Study Looking at Long Term Blood Sugar Control in People With Type 2 Diabetes Treated With Xultophy® in Local Clinical Practice in Japan. (NCT04838743) | Novo Nordisk A/S | 2021-04-23 |
| A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes (NCT04698018) | Novo Nordisk A/S | 2021-04-20 |
| Turoctocog Alfa in Haemophilic Italian Patients: Protection and Engagement in Recreational Activities (NCT04584892) | Novo Nordisk A/S | 2021-04-12 |
| Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) (NCT04822181) | Novo Nordisk A/S | 2021-04-01 |
| Post-Marketing Surveillance (Use-results Surveillance) With Esperoct® (NCT04334057) | Novo Nordisk A/S | 2021-03-31 |
| A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3) (NCT04795531) | Novo Nordisk A/S | 2021-03-24 |
| Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity (NCT04788511) | Novo Nordisk A/S | 2021-03-16 |
| A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin (NCT04770532) | Novo Nordisk A/S | 2021-03-05 |
| SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity (NCT04775082) | Novo Nordisk A/S | 2021-03-04 |
| A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before (NCT04760626) | Novo Nordisk A/S | 2021-03-01 |
| A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese and Non-Asian Men (NCT04722653) | Novo Nordisk A/S | 2021-02-02 |
| Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data (NCT04572165) | Novo Nordisk A/S | 2021-01-26 |
| An Indian Post Marketing Study of Mealtime Insulin, Fiasp®, to Evaluate Its Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice (NCT03987802) | Novo Nordisk A/S | 2021-01-20 |
| Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes (NCT04707469) | Novo Nordisk A/S | 2021-01-15 |
| A Study of FT-7051 in Men With MCRPC (NCT04575766) | Novo Nordisk A/S | 2020-12-30 |
| A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People With Liver Disease (NCT04597697) | Novo Nordisk A/S | 2020-12-22 |
| Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa Pegol (NCT04682145) | Novo Nordisk A/S | 2020-12-09 |
| Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity. (NCT04251156) | Novo Nordisk A/S | 2020-12-08 |
| A Study Investigating the Distribution and Metabolism of Three 14C-labeled Radioactive Study Compounds (NCT04676906) | Novo Nordisk A/S | 2020-11-26 |
| A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before (NCT04460885) | Novo Nordisk A/S | 2020-11-25 |
| A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (NCT04601740) | Novo Nordisk A/S | 2020-11-17 |
| A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Sweden, as Part of Local Clinical Practice (NCT04601753) | Novo Nordisk A/S | 2020-11-12 |
| A Study to Look at How Safe Insulin NNC0471-0119 is and How it Works in People With Type 1 Diabetes Mellitus (NCT04655690) | Novo Nordisk A/S | 2020-11-09 |
| A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes (NCT04596631) | Novo Nordisk A/S | 2020-11-02 |
| A Study Following Males With Haemophilia A on Prophylaxis With Esperoct® (NCT04574076) | Novo Nordisk A/S | 2020-10-23 |
| Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan. (NCT04626505) | Novo Nordisk A/S | 2020-10-22 |
| A Research Study Looking at Long-term Blood Sugar Control in People With Type 2 Diabetes Being Treated With Xultophy® in a Real-world Setting in Italy (NCT04666987) | Novo Nordisk A/S | 2020-10-21 |
| A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine (NCT04575181) | Novo Nordisk A/S | 2020-10-21 |
| A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice (NCT04559815) | Novo Nordisk A/S | 2020-10-21 |
| A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Insulin Icodec in Subjects With Type 2 Diabetes (NCT04582435) | Novo Nordisk A/S | 2020-10-16 |
| Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes (NCT04588259) | Novo Nordisk A/S | 2020-10-09 |
| A Study Looking at How Insulin Icodec is Taken up in the Blood When Administered in Different Injection Sites in People With Type 2 Diabetes (NCT04582448) | Novo Nordisk A/S | 2020-10-01 |
| A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes (NCT04560998) | Novo Nordisk A/S | 2020-10-01 |
| A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes (NCT04569994) | Novo Nordisk A/S | 2020-09-30 |
| Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People (NCT04524832) | Novo Nordisk A/S | 2020-09-29 |
| A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times (NCT04513704) | Novo Nordisk A/S | 2020-08-28 |
| A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Denmark, as Part of Local Clinical Practice (NCT04537637) | Novo Nordisk A/S | 2020-08-28 |
| A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (NCT04537624) | Novo Nordisk A/S | 2020-08-24 |
| Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic® (NCT04469855) | Novo Nordisk A/S | 2020-07-27 |
| Injection Site Pain Comparison of Excipient Solutions (NCT04482725) | Novo Nordisk A/S | 2020-07-20 |
| Clinical Outcomes of NovoSeven® Treatment in Severe Postpartum Haemorrhage - a Study at the University Hospital of Bern (NCT04444856) | Novo Nordisk A/S | 2020-06-29 |
| A Research Study, Looking at How NovoMix® Works in People With Type 2 Diabetes in Local Clinical Practice in Algeria (NCT03862690) | Novo Nordisk A/S | 2020-05-28 |
| A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Russia (NCT04315688) | Novo Nordisk A/S | 2020-03-30 |
| SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes (NCT04287179) | Novo Nordisk A/S | 2020-03-09 |
| A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 Diabetes (NCT04262661) | Novo Nordisk A/S | 2020-03-02 |
| First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes (NCT04259801) | Novo Nordisk A/S | 2020-02-17 |
| A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY) (NCT04261933) | Novo Nordisk A/S | 2020-02-13 |
| A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens (NCT04238962) | Novo Nordisk A/S | 2020-02-03 |
| A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy (NCT05503927) | Novo Nordisk A/S | 2020-02-01 |
| A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of Semaglutide (NCT04228354) | Novo Nordisk A/S | 2020-01-29 |
| A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in China (NCT04227431) | Novo Nordisk A/S | 2020-01-17 |
| A Research Study Looking Into Blood Levels of NNC0174-0833 in People With Normal and Impaired Kidney Function (NCT04209049) | Novo Nordisk A/S | 2020-01-15 |
| A Research Study Investigating Mim8 in People With Haemophilia A (NCT04204408) | Novo Nordisk A/S | 2020-01-10 |
| Effect of Fiasp® in Type 1 Diabetes Treatment (NCT03895515) | Novo Nordisk A/S | 2020-01-03 |
| A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity (NCT04187300) | Novo Nordisk A/S | 2019-12-16 |
| Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc (NCT04189848) | Novo Nordisk A/S | 2019-12-03 |
| A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection Pens (NCT04152915) | Novo Nordisk A/S | 2019-11-25 |
| Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors (NCT04082429) | Novo Nordisk A/S | 2019-11-13 |
| A Study to Look at How Safe NNC0268-0965 is in People With Type 2 Diabetes (NCT04136067) | Novo Nordisk A/S | 2019-10-29 |
| A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity (NCT04143945) | Novo Nordisk A/S | 2019-10-28 |
| A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 (NCT03847909) | Novo Nordisk A/S | 2019-10-28 |
| A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice (NCT04094415) | Novo Nordisk A/S | 2019-10-28 |
| Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors (NCT04083781) | Novo Nordisk A/S | 2019-10-21 |